3644 results for «2636»
3644 results
Refractory heart failure: combining oral therapy and device is key
21 May 2025 – From EuroPCR 2025
Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.
Precision in mitral TEER
11 Sep 2025 – From PCR Rio Valves 2025
Join this live educational session from Bordeaux University Hospital to gain expert insights into mitral transcatheter edge-to-edge repair (TEER). Explore optimal timing and clinical decision-making for mitral regurgitation treatment, and discover how the PASCAL Precision system enhances procedural precision across diverse mitral anatomies. Witness real-time strategies,...
All you need to know about transcatheter tricuspid therapies
11 Sep 2025 – From PCR Rio Valves 2025
Delve into the evolving field of transcatheter tricuspid therapies with this comprehensive session. Understand tricuspid valve anatomy and imaging modalities, discuss optimal timing for intervention in tricuspid regurgitation, and review current and emerging transcatheter treatment options. Case presentations illustrate practical applications and outcomes to support clinical...
Mitral valve - How to evaluate?
11 Sep 2025 – From PCR Rio Valves 2025
This educational session focuses on comprehensive evaluation of the mitral valve to guide clinical decision-making. Topics include risk stratification and patient selection for Mitral TEER, detailed anatomy review, assessment of primary and secondary mitral regurgitation phenotypes, advanced quantification techniques per current guidelines, and pre-intervention transoesophageal echocardiography...
EuroPCR 2025 Closing Ceremony
23 May 2025 – From EuroPCR 2025
Conclude your conference experience with the EuroPCR 2025 Closing Ceremony, celebrating the achievements, innovations, and advancements presented throughout the event, and setting the stage for future developments in interventional cardiology.
Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award
21 May 2025 – From EuroPCR 2025
Celebrate innovation and research excellence in interventional cardiology with the Jon DeHaan Foundation Award and Michele Pighi Young Investigator Award session. This session highlights groundbreaking work and emerging talent shaping the future of cardiovascular interventions.
Andreas Grüntzig Ethica Award
22 May 2025 – From EuroPCR 2025
Recognize excellence in interventional cardiology with the prestigious Andreas Grüntzig Ethica Award. This session honors outstanding contributions and ethical standards that advance the field and improve patient care worldwide.
Aortic stenosis doesn't play alone: TAVI in multivalvular and coronary artery disease patients
11 Sep 2025 – From PCR Rio Valves 2025
Managing aortic stenosis becomes even more challenging when it coexists with coronary artery disease (CAD) or multivalvular pathology. For patients with CAD, careful assessment of symptoms, lesion severity, and anatomy guides whether PCI is best performed before, during, or after TAVI, always with future coronary access...
Valve-in-valve and coronary protection
11 Sep 2025 – From PCR Rio Valves 2025
Explore complex valve-in-valve procedures and coronary protection strategies through a series of challenging case presentations. Topics include management of high-risk valve-in-valve scenarios, strategies for degenerated aortic bioprostheses, innovative transcarotid approaches, fenestration stenting for late coronary obstruction, and analysis of valve embolisation events, providing valuable insights for...
Novelties on how to manage difficult TAVI situations
11 Sep 2025 – From PCR Rio Valves 2025
Stay at the forefront of TAVI management with this session highlighting novel approaches to difficult clinical scenarios. Topics include predictive scoring for pacemaker implantation, impact of baseline frailty on recovery, comparative imaging for coronary stenosis evaluation, physiology-guided PCI in TAVI patients, and outcomes of extrathoracic non-transfemoral...
Tailored transfemoral TAVI in complex anatomies - LIVE Case
11 Sep 2025 – From PCR Rio Valves 2025
Supported by an unrestricted educational grant from Medtronic
An 89-year-old male with hypertension, dyslipidemia, current smoking, stage III kidney disease, and a history of diagonal PCI in 2010 presented with severe symptomatic aortic stenosis and a small annulus (410 mm²), with RBBB on ECG.
Via bilateral femoral access,...
The role of mitral TEER in advanced heart failure
11 Sep 2025 – From PCR Rio Valves 2025
This session delves into the role of mitral transcatheter edge-to-edge repair (TEER) in advanced heart failure patients. Understand the indications for mitral TEER in severe left ventricular dysfunction, prognostic challenges in heart failure with severe mitral regurgitation, and review therapeutic alternatives including the pathway from TEER...
Innovations in aortic valves
11 Sep 2025 – From PCR Rio Valves 2025
Discover the latest innovations in aortic valve technology in this comprehensive session. Explore initial clinical experiences with new self-expandable valves in small annuli, mid-term durability data of novel prostheses, and cutting-edge developments such as silver nanoparticle-coated valves and vascular protection implantable systems, providing a forward-looking perspective...
TAVI and structural imaging
11 Sep 2025 – From PCR Rio Valves 2025
This session addresses the critical role of structural imaging in TAVI procedures. Gain valuable knowledge on multimodal imaging approaches in TAVI-in-TAVI cases, complex paravalvular leak management, and unique complications after surgical valve replacement. The session also includes case studies highlighting combined treatments and challenges in severe...
Tricuspid valve TEER workshop
29 Sep 2025 – From PCR Gulf Valves 2025
This workshop provides a comprehensive understanding of tricuspid valve anatomy, echocardiographic screening, and procedural guidance essential for successful tricuspid TEER. Learn to distinguish suitable candidates and gain hands-on experience with intra-procedural echocardiography techniques.
Prediction and prevention of coronary artery obstruction during TAVI
29 Sep 2025 – From PCR Gulf Valves 2025
This session delivers expert insights into predicting and preventing coronary artery obstruction during TAVI procedures. Attendees will learn comprehensive assessment strategies for both native and bioprosthetic valves and explore advanced techniques to minimize occlusion risk in high-risk patients, including discussion of the UNICORN approach.
Advanced mitral valve TEER echocardiography
29 Sep 2025 – From PCR Gulf Valves 2025
Delve into advanced echocardiographic techniques for mitral valve TEER in this session. Gain expert knowledge on transseptal access, managing complex anatomical challenges, and practical strategies to navigate difficult and high-risk TEER procedures effectively.
Hot topics: complex structural cases on mitral stenosis, alternative access and electrosurgery
29 Sep 2025 – From PCR Gulf Valves 2025
This session highlights cutting-edge approaches to complex structural heart cases, including mitral stenosis management via balloon valvuloplasty, alternative access methods such as transcaval TAVI, and innovative solutions for failed mitral TEER procedures, providing comprehensive technical insights and case resolutions.
CT assessment for TAVI
29 Sep 2025 – From PCR Gulf Valves 2025
This educational session focuses on the critical role of CT angiography in TAVI planning. Attendees will learn to identify key anatomical landmarks, perform accurate measurements, and interpret imaging data to optimize patient selection and procedural success through a multimodal approach.
Step-by-step TAVI for mixed bicuspid aortic valve disease - LIVE Case
30 Sep 2025 – From PCR Gulf Valves 2025
A 65-year-old female with a history of diabetes and moderate left ventricular dysfunction (LVEF 50%) presented with symptomatic severe bicuspid aortic stenosis associated with moderate-to-severe aortic regurgitation. A 26 mm Sapien Resilia valve was implanted under local anesthesia via femoral artery access, with right radial secondary...
